Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Cash Flow Reinvestment Rate
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow Reinvestment Rate of 1.83x as of September 2025, reinvesting CN¥72.46 Million (capex CN¥72.46 Million ) from operating cash flow of CN¥39.68 Million. Check Xizang Haisco Pharmaceutical Group Co Lt earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Explore 002653 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Xizang Haisco Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Xizang Haisco Pharmaceutical Group Co Lt market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥494.23 Million | CN¥786.00 Million | CN¥331.98 Million | ▼ -49.3% |
| 2024 | 1.24x | CN¥548.28 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -28.0% |
| 2023 | 1.72x | CN¥774.20 Million | CN¥449.58 Million | CN¥391.01 Million | ▼ -81.1% |
| 2022 | 9.09x | CN¥859.79 Million | CN¥94.55 Million | CN¥700.17 Million | ▼ -78.1% |
| 2021 | 41.47x | CN¥1.48 Billion | CN¥35.80 Million | CN¥702.94 Million | ▲ +879.6% |
| 2020 | 4.23x | CN¥873.05 Million | CN¥206.21 Million | CN¥601.72 Million | ▲ +440.7% |
| 2019 | 0.78x | CN¥598.43 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -10.4% |
| 2018 | 0.87x | CN¥413.11 Million | CN¥472.61 Million | CN¥351.98 Million | ▼ -31.4% |
| 2017 | 1.27x | CN¥499.13 Million | CN¥391.81 Million | CN¥393.26 Million | ▲ +135.2% |
| 2016 | 0.54x | CN¥221.61 Million | CN¥409.20 Million | CN¥208.24 Million | ▼ -18.7% |
| 2015 | 0.67x | CN¥295.16 Million | CN¥443.03 Million | CN¥283.68 Million | ▲ +42.6% |
| 2014 | 0.47x | CN¥234.86 Million | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥163.98 Million | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥125.30 Million | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥117.72 Million | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥80.95 Million | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥24.01 Million | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥37.38 Million | CN¥94.45 Million | CN¥37.38 Million | — |